SHUTA ISHIGAMI to Feasibility Studies
This is a "connection" page, showing publications SHUTA ISHIGAMI has written about Feasibility Studies.
Connection Strength
0.110
-
Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2015 Feb 13; 116(4):653-64.
Score: 0.088
-
Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1198-1207, 1208.e1-2.
Score: 0.023